|Targeted News Service|
As the founder and co-chair of the
Moreover, diabetes is one of our costliest diseases in economic terms. It costs our nation more than
Despite these alarming statistics, the good news is that we are making progress. Due to the Special Diabetes Program and increased investments in diabetes research, we have seen some encouraging breakthroughs and are on the threshold of a number of important new discoveries.
This is particularly true for the estimated three million Americans living with type 1 diabetes. Advances in technology, like continuous glucose monitors, are helping patients control their blood glucose levels, which is key to preventing costly and sometimes deadly diabetes complications. We are also moving closer and closer to our goal of an artificial pancreas, which would control blood glucose levels automatically and revolutionize diabetes care.
A CGM is a physician-prescribed,
As demonstrated by extensive clinical evidence, adults using a CGM have had improved overall glucose control and have reduced rates of hypoglycemia or low blood glucose levels. Professional medical societies, including the
The ironic thing is that it is only because of advances in diabetes care like the continuous glucose monitor that people with type 1 diabetes can expect to live long enough to become
I have therefore joined my colleague from